Commercial aviation authority Joselito Geraldo de Sousa, widely recognized as Lito Sousa, passed away at age 59 on Thursday, October 1, 2026, at his home in São Paulo due to complications from Creutzfeldt-Jakob disease. The veteran aircraft technician and creator of the Aviões e Músicas platform, whose digital audience numbered roughly 3.7 million subscribers, had been receiving home hospice support. He is survived by his wife, business executive Mila Seidl, and their 7-year-old son, Malone.
The news of his death was shared by his widow across official social channels, paying homage to his life and career. In her statement, Seidl declared that the great commander chose to summon him to his side, reuniting him with his parents and his brother Geraldo. She added that while explaining his departure remains impossible, his completed journey represents a life of purpose, technical excellence, and dedication to flight safety.
Decades in commercial aircraft maintenance and digital outreach
Born in the northeastern Brazilian city of Natal on January 25, 1967, Sousa took his earliest professional steps in aviation at age 14 by joining the Brazilian Air Force (FAB). Across an expansive 37-year technical career, he performed critical maintenance operations for major domestic and international carriers, including Varig, Transbrasil, and United Airlines. At United Airlines, he rose through the operational ranks to serve as international maintenance chief before stepping down into retirement.
Transitioning into communication, he established the YouTube channel Aviões e Músicas and founded the specialized training venture Lito Academy. Sousa achieved broad national prominence by demystifying complex aeronautical engineering, routine cockpit protocols, and high-profile aviation disasters. His clear technical breakdowns guided the public through landmark tragedies, including the air crashes that claimed the musical group Mamonas Assassinas, the Chapecoense football team, and singer Marília Mendonça.
Check out: Skydive Milwaukee jumpers parachute to save plane crash victims
Summary of milestones and career achievements
- Official confirmation of death: October 1, 2026, in São Paulo
- Age at the time of passing: 59 years old
- Career duration: 37 years dedicated to aircraft maintenance and technical safety
- Online audience: approximately 3.7 million subscribers on Aviões e Músicas
- Surviving family members: wife Mila Seidl and 7-year-old son Malone
Pioneering application of experimental RNA technology for prion disorder
Amid the rapid escalation of his neurological illness, Sousa became the first human subject worldwide to receive an experimental therapeutic known as ALN-6457. The investigational short interfering RNA (siRNA) candidate was engineered through an international research collaboration between biotechnology developers Regeneron and Alnylam. Prior to this compassionate intervention, the compound had undergone only pre-clinical testing in animal models, with no prior human safety or efficacy trials.
The groundbreaking medical procedure was made possible through extraordinary regulatory clearance from the Brazilian Health Regulatory Agency, Anvisa. The custom shipment landed at an international air terminal in Brazil during the early hours of September 12, 2026, transported directly from laboratory facilities in the United States. The cargo cleared customs through coordinated emergency protocols executed alongside the Federal Revenue Service.
Key milestones from medical diagnosis through hospice care
- July 17, 2026: Sousa announces an initial medical assessment involving prostate cancer and acute encephalitis
- August 21, 2026: Family confirms diagnosis of Creutzfeldt-Jakob disease following rapid loss of motor coordination
- September 4, 2026: Anvisa grants exceptional compassionate import approval for the experimental molecule ALN-6457
- September 12, 2026: The investigational shipment arrives in Brazilian territory aboard a flight from the United States
- October 1, 2026: Sousa passes away at his private residence in São Paulo surrounded by family
Understanding Creutzfeldt-Jakob disease mechanisms and incidence figures
Creutzfeldt-Jakob disease represents an exceedingly rare, incurable neurodegenerative condition driven by misfolded infectious proteins known as prions. These abnormal structures systematically degrade central nervous system tissue, triggering steep and rapid decay in motor capabilities, memory, and cognitive functioning. Because no curative or disease-modifying options exist, medical literature indicates that roughly 90 percent of diagnosed individuals succumb to the pathology within twelve months of initial symptom onset.
Follow: Qantas to launch 18-hour direct flights connecting Sydney and New York by mid-2028
Public health authorities in Brazil incorporated the condition into the mandatory national disease surveillance network in 2005. Epidemiological data compiled by the Ministry of Health between 2005 and 2021 recorded 1,576 suspected notifications and 547 laboratory-confirmed cases nationwide. Medical tracking indicates that the overwhelming majority of these clinical occurrences developed among adults between 55 and 74 years of age.
Memorial arrangements, including the schedule and location for the wake and burial proceedings, have not yet been announced by the family. Further logistical updates regarding public tributes are expected to be shared through official family channels in the coming days.